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Abstract: Clostridium perfringens poses a serious threat to small ruminants by causing moderate to
severe enterotoxaemia. Due to its ability to produce a wide arsenal of toxins, it is ranked among
the most prevalent and important pathogens in livestock. This study focused on the molecular
characterization of different Clostridium perfringens types along with their antimicrobial resistance
profile. An overall higher prevalence of C. perfringens (46.1%) was detected based on mPCR among
sheep and goats (healthy and diseased) in the Punjab province, Pakistan. The majority of the isolates
were characterized as type A (82%), followed by type D (18%). Among the isolates from diseased
sheep and goats, 27% were positive for cpa, 49% for cpa and cpb2, 9% for cpa and etx, 15% for cpa,
cpb2 and etx. In the case of isolates from healthy sheep and goats, 59% were positive for cpa, 34% for
cpb2 and cpa, 4% for cpa and etx, and 3% for cpa, cpb2 and etx. The prevalence of the beta2 toxin
gene in the diseased sheep and goat population was 64% as compared to 37% in healthy animals.
All 184 isolates (100%) were sensitive to rifampin and ceftiofur; the majority (57%) was sensitive to
teicoplanin, chloramphenicol, amoxicillin, linezolid and enrofloxacin. A lower proportion of isolates
(43%) were sensitive to ciprofloxacin and only 14% were susceptible to erythromycin. The findings
of this study highlight the higher prevalence of C. perfringens in small ruminants and indicate that
detailed pathogenesis studies are necessary to understand the explicit role of various toxins in causing
enteric infections in sheep and goats including how they might be exploited to develop vaccines
against these diseases.
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Key Contribution: This is the comprehensive study on phenotypic and genotypic characterization of
C. perfringens strains in the relatively novel geographic location. Prevalence was described for the cpb2
gene (significantly enriched in isolates originating from diseased animals) and a few type D isolates
from healthy sheep and goats. Besides this, there is some useful information regarding antibiotics
resistance profile of these isolates, notably revealing higher intrinsic resistance against tetracycline.
1. Introduction
The livestock industry is one of the fastest growing and financially important sub-sectors of the
economy in developing countries like Pakistan, accounting for a 60.54% value addition to the Pakistani
agricultural sector and contributing 11.22% to GDP. Furthermore, it makes a significant contribution to
rural economic growth, where 40% of the population is dependent on livestock [1]. Small ruminants,
especially sheep and goats, are required for the subsistence of poor livestock owners and are a main
source of meat, milk, manure and skin [2]. Unfortunately, over the last decade, the caprine and ovine
industry has significantly declined due to infectious diseases [3]. Clostridium perfringens is one of the
main pathogens responsible for intestinal infections as well as histotoxic diseases in animals, having a
low incidence rate (2–8%) but a very high case fatality rate (100%) [4,5]. It is a gram positive, anaerobic,
spore-forming microorganism that produces more than 20 extracellular toxins and hydrolytic enzymes,
of which six are currently used for typing [6]. The toxins form diverse combinations and can be
divided into types A–G. All types produce α-toxin; in addition, type B produces β- and ε-toxin, type C
produces β-toxin, type D produces ε-toxin, type E produces ι-toxin, type F produces enterotoxin
and type G produces netB toxin [7,8]. All these potent toxins can act locally or are absorbed in the
intestine causing enteric infections, which are generically named as enterotoxemia in sheep and goats.
However, the severity of these infections is dependent on the type and combination of various toxins,
of which epsilon toxin (type D) is the most frequent cause of enterotoxemia in sheep and goats [9].
C. perfringens type A is involved in acute enterotoxemia in the goat kids [10]. Type D is associated
with “pulpy kidney disease” and dysentery in sheep [11]. Epsilon toxin, present in C. perfringens type
B and D, is mostly involved in disease pathogenesis [7]. Epsilon toxin in goats causes enterocolitis,
but in sheep it can also cause abnormal effects on the brain and lungs. The difference in pathogenesis
between the two species is due to the different mechanisms by which epsilon toxin modifies water and
ion transport in the intestines of sheep and goats [12–14]. In developed countries, C. perfringens type F
food poisoning is a commonly reported food-borne illness [15]. Strains carrying the CPE gene (cpe),
isolated from both humans and animals, produce spores in the intestinal tract. These spores produce
enterotoxin (CPE), which is responsible for symptoms such as diarrhea [16,17].
Although C. perfringens can exist as part of the normal intestinal microflora, under certain
conditions where the physiological balance of the intestine is altered, abnormal proliferation of this
microorganism can result in the production of a wide variety of toxins [18]. These toxins either act locally
or are absorbed into the general circulation, resulting in severe effects on the host [19]. Accurate typing
of the toxin is very important in disease diagnosis [20]. Traditionally, typing of C. perfringens strains has
been performed using a toxin neutralization test with the appropriate antisera in laboratory animals
such as guinea pigs [21]. An ELISA (enzyme-linked immunosorbent assay) based method can also
be used for typing C. perfringens isolates. However, these methods are often time-consuming and
are not always able to identify a range of different toxins, thereby limiting subtyping options [22].
In addition, special culture methods are required to induce sporulation, which aids in the identification
of enterotoxin producing strains [23]. Genotyping of C. perfringens isolates, however, can overcome this
problem and has become the standard for toxinotyping of C. perfringens. Polymerase chain reaction
(PCR) protocols, especially multiplex PCR assay, have been established for simultaneous detection of
these toxin genes (cpa, cpb, etx, iap, cpe and cpb2) [24–27].
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Although vaccines and different antimicrobial agents are used to control enterotoxaemia [28],
the extensive use of these agents to increase the growth rate of livestock animals and treat gastrointestinal
infections likely serves as a way of transmitting antimicrobial-resistant genes or microbes into the
human food chain [29,30]. The emerging problem of antimicrobial resistance between pathogenic
and commensal bacteria is also of concern [31]. There are very few reports on the antibiogram of
C. perfringens isolates recovered from sheep and goats in Pakistan. More comprehensive epidemiological
information pertaining to C. perfringens type A and D in these animals is also lacking. As such, the aim
of the present study was the isolation, phenotypic, genotypic and molecular typing of C. perfringens
type A and D isolates from diseased and healthy sheep and goats in the Punjab province of Pakistan,
as well as the analysis of their antimicrobial susceptibility patterns.
2. Results
2.1. Isolation and Identification of C. perfringens
A total of 201 samples (50.31%) from both sheep and goats were found positive and exhibited
typical black colonies on tryptose sulphite cycloserine agar plates. Most of isolates showed the presence
of Gram-positive rods and possessed subterminal spores. On blood agar, characteristic beta hemolytic
colonies with double zone of hemolysis were observed. The microorganism produced an opaque
halo around colonies on egg yolk agar, confirming it as C. perfringens whereas most other Clostridia
are reported to be lecithinase negative. All culture positive isolates were further resolved through
biochemical differential tests and sugar fermentation reactions. Almost all isolates fermented glucose,
maltose, sucrose, lactose, mannose and trehalose, while arabinose, cellobiose, mannitol, melezitose,
salicin, xylose, sorbitol and rhamnose were not fermented by C. perfringens isolates (Table 1). Two sugars
behaved differently in different isolates. Glycerol was fermented by one group of isolates while the
other group did not ferment it. Variations were also seen in the case of raffinose sugar, i.e., most of the
isolates did not ferment this sugar while only a few fermented it. There were also slight variations
in the biochemical properties of different isolates. All isolates hydrolyzed gelatin and were negative
for urease production. In addition, very few (2%) isolates hydrolyzed esculin. The indole test was
negative in all of the isolates; however, there was one isolate that behaved differently (i.e., indole was
positive). Biochemical characterization, therefore, differentiated the isolates into four major groups;
these are given in Table 2. It was found that 195 (48.9%) culture isolates belong to C. perfringens on the
basis of biochemical characterization.
Table 1. Carbohydrate fermentation reactions of C. perfringens field isolates. These isolates were placed
in groups on the basis of variation in the fermentation reactions of sugars by different isolates.
Groups Carbohydrate Fermentation
Clostridium
perfringens
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Group I isolates + − + + + − − − + − + − − − − +
Group II isolates + − + + + − − − − − + − − − − +
Group III isolates + − + + + − − − − − + − + − − +
Group IV isolates + − + + + − − − + − + − + − − +
Esculin positive
isolates (2%) + − + + + − − − + − + − − − − +
Indole positive
isolate (<1%) + − + + + − − − + − + − − − − +
+: indicates sugar fermentation and −: no sugar fermentation.
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Table 2. Biochemical characteristics of C. perfringens isolates.
Microorganism Egg Yolk Agar Biochemical Tests
Clostridium
perfringens
Lecithinase
Production
Lipase
Production
Gelatin
Hydrolysis
Indole
Production
Urease
Test
Esculin
Hydrolysis
Catalase
Test
Group I, II, III,
IV isolates + − + − − − −
Esculin positive
isolates (2%) + − + − − + −
Indole positive
isolate (<1%) + − + + − − −
+: positive reaction and −: negative reaction.
2.2. Toxinotyping of Recovered C. perfringens Isolates
All 195 biochemically characterized isolates of C. perfringens were examined for alpha, beta, epsilon,
iota, beta2 and enterotoxin gene by using the multiplex PCR technique. The alpha toxin gene (cpa) was
found to be present in 184 out of 399 (46.1%) isolates by simple PCR. These 184 isolates were further
genotyped using mPCR to further identify them as either type A or type D; and categorized on the
basis of presence of major toxin genes. Type A isolates had an alpha gene while type D isolates had alpha
and epsilon genes. Neither beta nor iota genes were present in any of the genotyped isolates. In addition
to alpha and epsilon genes, beta2 was also found in both type A and type D isolates. Eighty-two percent
of the isolates from sheep and goats belonged to C. perfringens Type A while 18% of the isolates were
C. perfringens type D (Figure 1).
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Figure 1. garose gel electrophoresis of PCR products. Lanes: , ti e c trol ( o te late );
2, 1000 bp ladder; 3,4,8, C. perfringens isolate (genotype A, β2); 5,10, . erfri ge s is late ( e otype );
6, C. perfringens isolate (genotype D); 7,9, C. perfringens isolate (genotype D, β2); 1 , Positive control.
A ong the isolates fro healthy sheep and goats, 59 ere positive for cpa, 34 for cpb2 and
cpa, 4% for cpa and etx, and 3% for cpa, cpb2 and etx. In the case of isolates from diseased sheep and
goats, 27 were positive for cpa, 49 for cpa and cpb2, 9 for cpa and etx, and 15% for cpa, cpb2 and
etx. erefore, t e erce tage of isolates that ere positive for cpb2 was significantly higher in the
diseased population (64%) of sheep and goats as compared to the healthy po ulation (37%). As far as
the presence of etx gene was concerned, 24% of isolates from the diseased population had the etx gene,
compared to 7% from the healthy population. The percentage of cpa and cpb2-positive isolates from
diseased animals (49%) was significantly higher than that of ealthy animals (34%). No isolates from
both populations were found to carry cpb, iap and cpe (Tables 3 and 4).
2.3. Antimicrobial Susceptibility Patterns
A total of 184 C. perfringens type A and D isolates confirmed by mPCR were used for in vitro
antimicrobial susceptibility testing (Figure 2). All the C. perfringens isolates showed 100% susceptibility
to rifampin and ceftiofur, while teicoplanin and enrofloxacin showed “significant susceptibility”
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against 57% of the C. perfringens isolates. Teicoplanin showed “good susceptibility” against
29% of the isolates while enrofloxacin showed good susceptibility against 43% of the isolates of
C. perfringens. Chloramphenicol, amoxicillin and linezolid showed significant susceptibility against
57% of C. perfringens isolates. Erythromycin showed significant susceptibility to 14% isolates while good
susceptibility was observed against 72% of the isolates. Norfloxacin showed “moderate susceptibility”
against 100% of the isolates. Ciprofloxacin showed significant susceptibility against 43% of the
isolates while 29% and 28% of the isolates showed good and moderate susceptibility, respectively.
All C. perfringens isolates showed 100% resistance against neomycin and 72% resistance to tetracycline
as shown in Table 5.
Table 3. Multiplex PCR results for the C. perfringens isolates (sheep and goat).
S. No. Toxin Gene ofC. perfringens C. perfringens Type Positive Cases
Total Fecal
Samples Collected Animal
1. Alpha, epsilon, beta2
A
65 (Diseased 42 +
Healthy 23) 148 Goat
Aβ2
D
D β2
2. Alpha, epsilon, beta2
A
119 (Diseased 76
+ Healthy 43) 251
SheepA
β2
D
D β2
Table 4. Multiplex PCR results for the C. perfringens isolates (healthy and diseased).
Positive Gene(s)
Isolate Population
Healthy (n = 68) Diseased (n = 116)
cpa (Type A) * 40 (59%) 31 (27%)
cpa, cpb2 (Type A, cpb2) * 23 (34%) 57 (49%)
cpa, etx (Type D) 3 (4%) 11 (9%)
cpa, etx, cpb2 (Type D, cpb2) 2 (3%) 17 (15%)
* significantly different values in a row (p < 0.05).
2.4. Antimicrobial Susceptibility Patterns
A total of 184 C. perfringens type A and D isolates confirmed by mPCR were used for in vitro
antimicrobial susceptibility testing (Figure 2). All the C. perfringens isolates showed 100% susceptibility
to rifampin and ceftiofur, while teicoplanin and enrofloxacin showed “significant susceptibility”
against 57% of the C. perfringens isolates. Teicoplanin showed “good susceptibility” against
29% of the isolates while enrofloxacin showed good susceptibility against 43% of the isolates of
C. perfringens. Chloramphenicol, amoxicillin and linezolid showed significant susceptibility against
57% of C. perfringens isolates. Erythromycin showed significant susceptibility to 14% isolates while good
susceptibility was observed against 72% of the isolates. Norfloxacin showed “moderate susceptibility”
against 100% of the isolates. Ciprofloxacin showed significant susceptibility against 43% of the
isolates while 29% and 28% of the isolates showed good and moderate susceptibility, respectively.
All C. perfringens isolates showed 100% resistance against neomycin and 72% resistance to tetracycline
as shown in Table 5.
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Table 5. Antibiotic susceptibility testing of Clostridium perfringens against different antibiotics.
Antibiotics
Number of Strains of Clostridium perfringens with Percentage of Inhibition
Significant
Susceptibility
(>70% Inhibition)
Good Susceptibility
(60–70% Inhibition)
Moderate
Susceptibility
(40–60% Inhibition)
Resistant
(≤40% Inhibition)
Tetracycline (30 µg) 26/184(14%) 00 26/184(14%) 132/184(72%)
Teicoplanin (30 µg) 105/184(57%) 53/184(29%) 26/184(14%) 00
Enrofloxacin (5 µg) 105/184(57%) 79/184(43%) 00 00
Chloramphenicol (30 µg) 105/184(57%) 26/184(14%) 53/184(29%) 00
Rifampin (5 µg) 184/184(100%) 00 00 00
Amoxicillin (10 µg) 105/184(57%) 79/184(43%) 00 00
Penicillin G (10 µg) 184/184(100%) 00 00 00
Ceftiofur (30 µg) 184/184(100%) 00 00 00
Ciprofloxacin (5 µg) 79/184(43%) 53/184(29%) 52/184(28%) 00
Erythromycin (15 µg) 26/184(14%) 132/184(72%) 26/184(14%) 00
Norfloxacin (10 µg) 00 00 184/184(100%) 00
Linezolid (30 µg) 105/184(57%) 26/184(14%) 53/184(29%) 00
Neomycin (10 µg) 00 00 00 184/184(100%)
3. Discussion
Clostridium perfringens ranks among the most important pathogens in livestock and humans,
and it causes both histotoxic disease and infection originating in the intestines. Toxins produced by
C. perfringens types are responsible for enteric diseases in sheep and goats and it has been suggested that
economic losses due to C. perfringens infections may be a result of all seven types of the bacterium [32,33].
There may be geographical differences in the prevalent types of the bacterium; also types may vary
depending on the animal species in the area [34]. In the present study, the biochemical results were
similar to previously reported findings, with few exceptions [35,36]. Very few isolates hydrolyzed
esculin and glycerol sugar was weakly fermented in some isolates; in some cases there was no
fermentation. Raffinose was only fermented in some isolates [37]. A variation was noted during indole
production reaction, although only a single isolate was found as indole positive. This variation is
significant as it has not been previously reported in the scientific literature. A study conducted in 1942,
however, supports this finding [38].
In this study, C. perfringens type A was present in 82% of samples collected from both healthy
and diseased sheep and goats. Different studies have reported C. perfringens type A in 51–87%
of samples taken from soil and healthy ruminants [39–41]. C. perfringens type A has also been
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reported as the most prevalent type in North America [42]. Another study conducted in Saudi Arabia
indicated that C. perfringens type A was the most prevalent type in sheep, calves and chicken [43].
Unfortunately, there are very few authentic reports citing the prevalence of C. perfringens in Pakistani
sheep and goat populations. C. perfringens type D causes diseases in numerous animal species; however,
it is more prevalent in sheep and goats. The results of our study indicated that C. perfringens type
D is prevalent in both healthy and diseased animals. About 18% of isolates from both healthy and
diseased sheep and goats belong to C. perfringens type D. In ruminants, this type is normally present
in the intestine even though different studies have isolated this type in less than 20% of the animals
and on some farms, no type D microorganism was found at all [41]. In this study, 5 type D isolates
out of 68 (7%) samples were found in healthy animals. Of these 5 samples, 2 were isolated from goat
and the other 3 isolates belonged to sheep. Type E infections in domestic animals were considered as
a rare occurrence. Likewise, no isolates in our study from healthy or diseased animals were found
to be C. perfringens type E. In numerous epidemiological studies, C. perfringens types possessing
the cpb2 gene have been isolated from cattle, horses, pigs, sheep, goats, poultry, fish, carnivores,
domestic wildlife species and humans [44,45]. In this study, the prevalence of beta2 toxin gene was
found to be significantly higher in diseased sheep and goats. In diseased animals, the cpb2 gene was
found in 64% of the isolates, compared to 37% in healthy animals. The high prevalence of the cpb2 gene
in isolates from animals with enteric problems is also consistent with previous studies from different
parts of the world [46].
The investigations carried out in control group (healthy sheep and goats) revealed that the most
prevalent type in these animals was type A (93%). This is because they have cpa only, while the other
7% of isolates have epsilon toxin gene in addition to the alpha gene, thus, they belong to type D. In one
study conducted in Turkey, 61 C. perfringens isolates from healthy sheep were examined by multiplex
PCR; of these, 95% belonged to type A and the remaining 5% were type D [47]. These results are similar
to those found in previous studies [48–50]. A study investigating the predominant flora of ostrich
intestine reported type A as the most prevalent type, while in the investigation of fecal samples of
diseased (Enteritis, Enterotoxemia) sheep and goats, C. perfringens type A was found in 76% of isolates.
Similarly, a study conducted in 2012 in Saudi Arabia reported type A in 73.5% of the genotyped
isolates [51]. Type A has also been reported as a predominant type in sheep with enterotoxemia [47].
Based on our findings, besides type A, C. perfringens type D was found in 24% of isolates from diseased
sheep and goats. Reports from various studies around the world have found that the prevalence of
type D enterotoxemia ranges from 24.13–100% [32]. In Turkey, the prevalence of type D enterotoxemia
in diseased animals was reported to be from 38.63–50% [49].
The present study ascertained the distribution of C. perfringens toxin types in sheep and goat
populations in relation to health status. The predominance of the alpha toxin gene (C. perfringens
type A) is in accordance with the high distribution of this toxin type in neighboring countries like
China, India and Bangladesh [52,53]. The high prevalence of alpha and beta2 genes also signifies the
need to incorporate these strains into the vaccine that is currently used against C. perfringens infections,
which contains only type D strain, and also suggests the use of an oil based/montanide adjuvanted
vaccine, which was proven successful against other clinically important diseases of livestock [54].
In addition, this study is the first of its kind to report the presence of epsilon toxin gene (etx) in the
feces of healthy sheep and goats raised in Pakistan.
In Pakistan, there are very few reports on the antibiotic resistance patterns of C. perfringens type A
and D isolated from an animal source. The present study revealed that all isolates were found to
be susceptible to penicillin, as mentioned in different studies reported from other countries [55,56].
In addition to penicillin, all isolates were also found to be susceptible to rifampin and ceftiofur.
These results were in agreement to those reported in Brazil and Thailand [57,58]. Amoxicillin and
enrofloxacin showed high in vitro activity against 57% of isolates and 60–70% inhibition against the
remaining 43% of isolates. Another study showed that all isolates from commercial turkeys were
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highly susceptible to amoxicillin and enrofloxacin [55]. The teicoplanin activity was also found to be in
accordance with the results described against intestinal anaerobic bacteria [59].
Norfloxacin, neomycin and tetracycline were least active against C. perfringens isolates from sheep
and goats. The poor efficacy of these antibiotics has also been previously reported in piglets [57].
Reduced susceptibility to tetracycline detected in C. perfringens isolates across all host species is
consistent with the findings of several studies from various countries [60,61]. In this study, 72% of
isolates were found to be resistant to tetracycline, which is more than previous findings [62]. This higher
incidence of tetracycline resistance in C. perfringens isolates is the result of the excessive use of this
antibiotic in the sampling areas, often following poor or incorrect veterinary advice. In the present
study, linezolid and chloramphenicol showed significant susceptibility against 57% of C. perfringens
isolates while ciprofloxacin and erythromycin showed intermediate susceptibility. Previous studies
have indicated that almost all isolates were susceptible to linezolid, chloramphenicol while resistance
against erythromycin antibiotic was reported for fewer isolates [56,62–64].
Our findings showed that tetracycline is a poor treatment choice for C. perfringens-associated
infections due to the decreased susceptibility among C. perfringens isolates. Therefore, the use of
tetracycline, particularly at low doses, could select for tetracycline resistant strains and result in the
transmission of tetracycline resistance.
4. Conclusions
In Pakistan, enteric diseases in small ruminants are causing annual losses of billions of rupees to
the sheep and goat industry. The high distribution of toxins in strains from clinically infected sheep and
goats also highlights their role in producing diseased conditions. Consequently, these initial findings
could be further used for epidemiological investigations, prophylaxis plans and control strategies by
formulating appropriate vaccines.
5. Materials and Methods
5.1. Sample Site and Isolation Source
A total n = 399 samples were collected aseptically in sterile plastic bags from sheep and goats in
selected districts (Faisalabad, Okara, DG Khan, Muzaffargarh, Bhakkar, Layyah) in the Punjab province,
Pakistan over a one year period using a convenient random sampling technique. Fecal samples
were collected from healthy and diseased animals following the inclusion and exclusion criteria.
Healthy sheep and goats included animals that were assessed as healthy with no history of diarrhea
and with normal fecal consistency. In addition, these animals had not received any other medical
treatment in the last month. Diseased animals included sheep and goats suffering from enteric disease
(having diarrhea or history of diarrhea) which may include fever, abdominal discomfort, lack of appetite
and a history of weight loss. Vaccinated animals (alum precipitated enterotoxemia vaccine) were also
included according to their health status either in the healthy or diseased group. Animals undergoing
any medical treatment in the last month were excluded from the study. Collected samples were
transported immediately to the laboratory under refrigerated conditions.
5.2. Isolation of C. perfringens
The fecal samples were diluted in phosphate buffered saline (PBS) 1:10 and placed in a water
bath for 10 min at 80 ◦C to kill the non-spore forming microorganisms. The processed samples were
sub-cultured in reinforced clostridial media (RCM) and then inoculated on tryptose sulfite cycloserine
agar (TSC) and 5% blood agar plates. The inoculated plates were kept in anaerobic jars at 37 ◦C for 24 h.
Anaerobiosis was created by using an anaerobe sachet. After initial identification based on characteristic
colony morphology and Gram staining, the colonies presenting C. perfringens characteristics were
streaked on egg yolk agar in order to confirm the lecithinase and lipase activity. Further biochemical
characterization was carried out using API 20A kits (bioMérieux, Marcy l’Étoile, France).
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5.3. Molecular Typing of C. perfringens Through Multiplex PCR (mPCR)
Following biochemical characterization, isolates found positive for C. perfringens were subjected to
molecular typing for identification of the prevalent toxin types. Molecular typing of C. perfringens was
performed by multiplex PCR technique. Accordingly, previously developed primers cpa, etx, cpb, iap,
cpe and cpb2 (Table 6) were used simultaneously for their ability to identify C. perfringens types [65–67].
Table 6. Oligonucleotide primers for multiplex PCR detection of C. perfringens toxin genes.
Toxin Gene Primers Primer Sequence (5′–3′) Product Size (bp)
cpa (α-toxin) CPA F GCTAATGTTACTGCCGTTGA 324 bp
CPA R CCTCTGATACATCGTGTAAG
cpb (β-toxin) CPB F GCGAATATGCTGAATCATCTA 195 bp
CPB R GCAGGAACATTAGTATATCTTC
cpb2 (β2-toxin)
CPB2 F AAATATGATCCTAACCAACAA 548 bp
CPB2 R CCAAATACTCTAATCGATGC
etx (ε-toxin) ETX F TGGGAACTTCGATACAAGCA 376 bp
ETX R AACTGCACTATAATTTCCTTTTCC
iap (ι-toxin) IA F AATGGTCCTTTAAATAATCC 272 bp
IA R TTAGCAAATGCACTCATATT
cpe
(enterotoxin)
CPE F TTCAGTTGGATTTACTTCTG 485 bp
CPE R TGTCCAGTAGCTGTAATTGT
Genomic DNA was extracted from all C. perfringens isolates using a manual method [34].
Colonies from 12–18 h pure culture of C. perfringens were suspended in 1 mL distilled water
(about 106 cells per mL). Centrifugation was done at 6000× g for 5 min. The supernatant was
discarded and cells were resuspended in 200 µL cold Tris EDTA (TE) Buffer. DNA was extracted using
EZ-10 Spin Column DNA Gel Extraction Kit (Bio Basic Inc., Toronto, Canada). Multiplex PCR was
performed in a thermal cycler with final volume of 25 µL for each reaction mixture. The reaction
mixture contained 1.25 U Taq DNA polymerase, 1X PCR Buffer, 4 mM MgCl2, 250 µM dNTPs, 0.12 µM
forward and reverse primers of alpha, epsilon, beta, iota and entero gene, 0.16 µM forward and
reverse primer of beta2 gene, 2 µL of sample DNA (150–200 ng/µL). The PCR conditions consisted of a
pre-denaturation phase at 95 ◦C for 10 min and 40 cycles of 94 ◦C for 45 s, 55 ◦C for 90 s, 72 ◦C for 90 s
followed by 72 ◦C for 10 min. The PCR product was electrophoresed on 1.5% agarose gel. DNA bands
were observed under UV transillumination and photographed using Alpha Imager Mini Imaging
System (San Jose, CA, USA).
5.4. Antimicrobial Susceptibility Testing
Antibiotic susceptibility assays were performed according to the disk diffusion method described
in [68]. Thirteen different antibiotics were selected on the basis of clinical relevance and veterinary farm
practices, belonging to different antimicrobial groups. The antibiotic discs used (Oxoid, Basingstoke,
UK) were as follows: amoxicillin (10 µg), ceftiofur (30 µg), chloramphenicol (30 µg), ciprofloxacin
(5 µg), enrofloxacin (5 µg), erythromycin (15 µg), linezolid (30 µg), neomycin (10 µg), norfloxacin
(10 µg), penicillin G (10 µg), rifampin (5 µg), teicoplanin (30 µg) and tetracycline (30 µg). Perfringens
agar medium (Oxoid, UK) was used as a growth medium for C. perfringens. A single colony from a
24 h fresh culture was dispensed in sterilized saline solution by using a sterilized inoculating loop.
After thorough mixing, the turbidity of the cultures was compared with standard McFarland solution.
If the broth was more turbid, they were adjusted through the addition of normal saline. Bacterial lawn
was made on the petri plates by dipping sterile cotton swab in bacterial inoculum. Antibiotic discs
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were placed on the inoculated plate at an appropriate distance from each other. Penicillin was taken as
a positive control. The clear zones of inhibition appeared around the discs of antibiotics after 24 h of
incubation at 37 ◦C.
The diameter of the zone around each antibiotic was measured in millimeters (mm) and calculated
as the mean of three replicates. The percentage of inhibition of antibiotics was calculated using the
formula described earlier by comparing it with the standard antibiotic (Penicillin) [68–70].
Percentage of Inhibition (%) =
Zone of inhibition of test antibiotic
Zone of inhibition of standard
× 100
5.5. Criteria for Bacterial Inhibition
The bacterial inhibition was carried out for C. perfringens isolates using the criteria mentioned
(Table 7).
Table 7. Inhibition Criteria for C. perfringens isolates.
Significant Level Growth Inhibition
Resistant ≤40% inhibition
Moderate Sensitivity 40–60% inhibition
Good Susceptibility 60–70% inhibition
Significant Susceptibility 70% and above
5.6. Statistical Analysis
The C. perfringens isolates identified from fecal samples of the control group and diseased group
of animals were screened by multiplex PCR (mPCR) and the results were presented in a tabularized
form. The health status-wise prevalence of C. perfringens types in different groups was compared by
Pearson’s chi-square test (χ2) using SPSS software, 22.0 version (IBM, New York, NY, USA).
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